Clostridium Difficile Infection-Reference-Cited by-同舟云学术

Clostridium Difficile Infection

Published:2014-10-24 Issue: Volume: Page:
ISSN:1866-0452
Container-title:Deutsches Ärzteblatt international
language:
Short-container-title:

Author:

Lübbert Christoph,John Endres,Müller Lutz von

Publisher

Deutscher Arzte-Verlag GmbH

Subject

General Medicine

Reference131 articles.

1. Cohen SH, Gerding DN, Johnson S, et al.: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431–55.

2. Rupnik M, Wilcox MH, Gerding DN: Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nature Rev Microbiol 2009; 7: 526–36.

3. Behnke M, Hansen S, Leistner R, et al.: Nosocomial infection and antibiotic use: a second national prevalence study in Germany. Dtsch Arztebl Int 2013; 110: 627–33.

4. Deshpande A, Pasupuleti V, Thota P, et al.: Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013; 68: 1951–61.

5. Ott E, Saathoff S, Graf K, Schwab F, Chaberny IF: The prevalence of nosocomial and community acquired infections in a university hospital: an observational study. Dtsch Arztebl Int 2013; 110: 533–40.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testing and Diagnosis of Clostridioides difficile Infection in Special Scenarios: A Systematic Review;Cureus;2024-04-25

2. Testing and diagnosis of Clostridioides difficile infection in special scenarios: A systematic review;2024-02-12

3. Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile;PLOS ONE;2024-01-19

4. PSEUDOMEMBRANOUS COLITIS. MICROBIOLOGICAL DIAGNOSIS AND TREATMENT;Themed collection of papers from Foreign international scientific conference «Joint innovation - joint development». Part 2. by HNRI «National development» in cooperation with PS of UA. October 2023. - Harbin (China);2024-01-18

5. Phenylthiazoles with potent & optimum selectivity toward Clostridium difficile;RSC Medicinal Chemistry;2024